Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-02-19

FDA Approved: KETOTIFEN FUMARATE OPHTHALMIC SOLUTION — Supplemental Application (Sentiss Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for Ketotifen Fumarate Ophthalmic Solution from Sentiss Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketotifen Fumarate Ophthalmic Solution (ketotifen fumarate)

Snippet

SUPPL AP for KETOTIFEN FUMARATE OPHTHALMIC SOLUTION (KETOTIFEN FUMARATE)